Gene · 8467
Papers1,650
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,650
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PAK1 overexpression promotes myxofibrosarcoma angiogenesis through STAT5B-mediated CSF2 transactivation: clinical and therapeutic relevance of amplification and nuclear entry. | Int J Biol Sci | 2023 | 37564209 | PubTator, text mining | PubMed |
| Comprehensive analysis of circRNAs for N7-methylguanosine methylation modification in human oral squamous cell carcinoma. | FASEB Bioadv | 2023 | 37554544 | PubTator, text mining | PubMed |
| Functionalized graphene-oxide grids enable high-resolution cryo-EM structures of the SNF2h-nucleosome complex without crosslinking. | bioRxiv | 2023 | 37546986 | PubTator, text mining | PubMed |
| Pluripotency-Associated microRNAs in Early Vertebrate Embryos and Stem Cells. | Genes (Basel) | 2023 | 37510338 | PubTator, text mining | PubMed |
| The HDAC6-RNF168 axis regulates H2A/H2A.X ubiquitination to enable double-strand break repair. | Nucleic Acids Res | 2023 | 37503842 | PubTator, text mining | PubMed |
| The role of mammalian Sirtuin 6 in cardiovascular diseases and diabetes mellitus. | Front Physiol | 2023 | 37497437 | PubTator, text mining | PubMed |
| ISW1a modulates cohesin distribution in centromeric and pericentromeric regions. | Nucleic Acids Res | 2023 | 37486771 | PubTator, text mining | PubMed |
| Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor. | Nat Commun | 2023 | 37460463 | PubTator, text mining | PubMed |
| SRSF1 induces glioma progression and has a potential diagnostic application in grading primary glioma. | Oncol Lett | 2023 | 37427339 | PubTator, text mining | PubMed |
| Oncogenic SRSF3 in health and diseases. | Int J Biol Sci | 2023 | 37416784 | PubTator, text mining | PubMed |
| Modulation of SIRT6 activity acts as an emerging therapeutic implication for pathological disorders in the skeletal system. | Genes Dis | 2023 | 37396554 | PubTator, text mining | PubMed |
| Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential. | Exp Mol Med | 2023 | 37394582 | PubTator, text mining | PubMed |
| Deregulated microRNAs Involved in Prostate Cancer Aggressiveness and Treatment Resistance Mechanisms. | Cancers (Basel) | 2023 | 37370750 | PubTator, text mining | PubMed |
| Circular RNA circBNC2 facilitates glycolysis and stemness of hepatocellular carcinoma through the miR-217/high mobility group AT-hook 2 (HMGA2) axis. | Heliyon | 2023 | 37360090 | PubTator, text mining | PubMed |
| Long non-coding RNA lncMGC mediates the expression of TGF-β-induced genes in renal cells via nucleosome remodelers. | Front Mol Biosci | 2023 | 37325470 | PubTator, text mining | PubMed |
| H4K16ac activates the transcription of transposable elements and contributes to their cis-regulatory function. | Nat Struct Mol Biol | 2023 | 37308596 | PubTator, text mining | PubMed |
| The Impact of NAD Bioavailability on DNA Double-Strand Break Repair Capacity in Human Dermal Fibroblasts after Ionizing Radiation. | Cells | 2023 | 37296639 | PubTator, text mining | PubMed |
| Maintaining chromosome and genome stability by the RPA-RNF20-SNF2H cascade. | Proc Natl Acad Sci U S A | 2023 | 37276422 | PubTator, text mining | PubMed |
| New molecular targets in Hodgkin and Reed-Sternberg cells. | Front Immunol | 2023 | 37266436 | PubTator, text mining | PubMed |
| Alzheimer's disease pathogenetic progression is associated with changes in regulated retained introns and editing of circular RNAs. | Front Mol Neurosci | 2023 | 37266374 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8467/papers?page=7